Moreover, our clinical analysis based on CRC patients revealed that CBX3 correlated negatively with almost all the members of JAK/STAT signaling, including JAK1, JAK2, STAT1, STAT2, and STAT3. This evidence concerns the gene CBX3 and colorectal carcinoma.